Cargando…

Pretubulysin: a new option for the treatment of metastatic cancer

Tubulin-binding agents such as taxol, vincristine or vinblastine are well-established drugs in clinical treatment of metastatic cancer. However, because of their highly complex chemical structures, the synthesis and hence the supply issues are still quite challenging. Here we set on stage pretubulys...

Descripción completa

Detalles Bibliográficos
Autores principales:	Braig, S, Wiedmann, R M, Liebl, J, Singer, M, Kubisch, R, Schreiner, L, Abhari, B A, Wagner, E, Kazmaier, U, Fulda, S, Vollmar, A M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4040707/ https://www.ncbi.nlm.nih.gov/pubmed/24434509 http://dx.doi.org/10.1038/cddis.2013.510

Ejemplares similares

Combined antitumoral effects of pretubulysin and methotrexate
por: Kern, Sarah, et al.
Publicado: (2019)

Pretubulysin: From Hypothetical Biosynthetic Intermediate to Potential Lead in Tumor Therapy
por: Herrmann, Jennifer, et al.
Publicado: (2012)

The pretubulysin-induced exposure of collagen is caused by endothelial cell retraction that results in an increased adhesion and decreased transmigration of tumor cells
por: Schwenk, Rebecca, et al.
Publicado: (2017)

The Microtubule-Targeting Agent Pretubulysin Impairs the Inflammatory Response in Endothelial Cells by a JNK-Dependent Deregulation of the Histone Acetyltransferase Brd4
por: Primke, Tobias F., et al.
Publicado: (2023)

Targeting the actin cytoskeleton: selective antitumor action via trapping PKCɛ
por: Foerster, F, et al.
Publicado: (2014)

New Treatment Options in Metastatic Pancreatic Cancer
por: Fudalej, Marta, et al.
Publicado: (2023)

New treatment options for metastatic renal cell carcinoma
por: Rodriguez-Vida, Alejo, et al.
Publicado: (2017)

The Actin Targeting Compound Chondramide Inhibits Breast Cancer Metastasis via Reduction of Cellular Contractility
por: Menhofer, Magdalena H., et al.
Publicado: (2014)

NIK is required for NF-κB-mediated induction of BAG3 upon inhibition of constitutive protein degradation pathways
por: Rapino, F, et al.
Publicado: (2015)

Current and Novel Treatment Options for Metastatic Colorectal Cancer: Emphasis on Aflibercept
por: Dietvorst, Maria H. P., et al.
Publicado: (2013)

Apatinib as an optional treatment in metastatic colorectal cancer
por: Li, Aiyi, et al.
Publicado: (2019)

Treatment options for metastatic melanoma in solid organ transplant recipients
por: Shin, Thuzar M., et al.
Publicado: (2015)

Ixabepilone: a new treatment option for the management of taxane-resistant metastatic breast cancer
por: Cobham, Marta Vallee, et al.
Publicado: (2009)

New treatment options for metastatic renal cell carcinoma with prior anti-angiogenesis therapy
por: Zarrabi, Kevin, et al.
Publicado: (2017)

Metastatic Prostate Cancer—A Review of Current Treatment Options and Promising New Approaches
por: Posdzich, Philip, et al.
Publicado: (2023)

Selecting treatment options in refractory metastatic colorectal cancer
por: Byrne, Margaret, et al.
Publicado: (2019)

Metastatic and locally aggressive BCC: Current treatment options
por: Casey, Máire‐Caitlín, et al.
Publicado: (2021)

Treatment options of metastatic and nonmetastatic VIPoma: a review
por: Azizian, Azadeh, et al.
Publicado: (2022)

IGFBP3 impedes aggressive growth of pediatric liver cancer and is epigenetically silenced in vascular invasive and metastatic tumors
por: Regel, Ivonne, et al.
Publicado: (2012)

Abfraction lesions: etiology, diagnosis, and treatment options
por: Nascimento, Marcelle M, et al.
Publicado: (2016)

New options in the management of intractable ALK(+) metastatic non-small-cell lung cancer
por: Weise, Amy M, et al.
Publicado: (2014)

Radium-223 Chloride: A New Treatment Option for Metastatic Castration-Resistant Prostate Carcinoma
por: Pinto, Álvaro, et al.
Publicado: (2012)

Update on options for treatment of metastatic castration-resistant prostate cancer
por: Vishnu, Prakash, et al.
Publicado: (2010)

Targeting metastatic colorectal cancer – present and emerging treatment options
por: Ciombor, Kristen K, et al.
Publicado: (2014)

Metastatic penile carcinoma – an update on the current diagnosis and treatment options
por: Barski, Dimitri, et al.
Publicado: (2014)

A novel combinatorial treatment option for metastatic uveal melanoma
por: Shneor, Dudi, et al.
Publicado: (2018)

Metastatic and triple-negative breast cancer: challenges and treatment options
por: Al-Mahmood, Sumayah, et al.
Publicado: (2018)

Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer
por: Cattrini, Carlo, et al.
Publicado: (2019)

Treatment Options for Germline BRCA-Mutated Metastatic Pancreatic Adenocarcinoma
por: Grzelak, Doreen
Publicado: (2021)

Surgical options for treatment of metastatic pleural disease: extended abstract
por: Okumura, Meinoshin
Publicado: (2022)

Ixabepilone: a new chemotherapeutic option for refractory metastatic breast cancer
por: Puhalla, Shannon, et al.
Publicado: (2008)

Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?
por: Passiglia, Francesco, et al.
Publicado: (2021)

Low-dose metronomic chemotherapy as an efficient treatment option in metastatic breast cancer—results of an exploratory case–control study
por: Krajnak, S., et al.
Publicado: (2020)

Turning the Actin Nucleating Compound Miuraenamide into Nucleation Inhibitors
por: Wang, Shuaijun, et al.
Publicado: (2021)

New Treatment Options in COPD
por: Hillman, Daniel E.
Publicado: (2005)

Treatment Options in Metastatic Renal Cell Carcinoma: Focus on mTOR Inhibitors
por: Pal, Sumanta Kumar, et al.
Publicado: (2010)

Persistent inhibition of pore-based cell migration by sub-toxic doses of miuraenamide, an actin filament stabilizer
por: Moser, Christina, et al.
Publicado: (2017)

Pazopanib for metastatic pulmonary epithelioid hemangioendothelioma—a suitable treatment option: case report and review of anti-angiogenic treatment options
por: Semenisty, Valeriya, et al.
Publicado: (2015)

Current Drug Treatment Strategies for Atrial Fibrillation and TASK-1 Inhibition as an Emerging Novel Therapy Option
por: Kraft, Manuel, et al.
Publicado: (2021)

Surveillance of Resistance to New Antibiotics in an Era of Limited Treatment Options
por: Morel, Chantal M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sqbe0i0827oue3p22ko5vp6bna